Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0684355B2 - Pyrimidinophenyl ester derivative - Google Patents
[go: Go Back, main page]

JPH0684355B2 - Pyrimidinophenyl ester derivative - Google Patents

Pyrimidinophenyl ester derivative

Info

Publication number
JPH0684355B2
JPH0684355B2 JP61206513A JP20651386A JPH0684355B2 JP H0684355 B2 JPH0684355 B2 JP H0684355B2 JP 61206513 A JP61206513 A JP 61206513A JP 20651386 A JP20651386 A JP 20651386A JP H0684355 B2 JPH0684355 B2 JP H0684355B2
Authority
JP
Japan
Prior art keywords
mol
liquid crystal
compound
ethyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP61206513A
Other languages
Japanese (ja)
Other versions
JPS6363665A (en
Inventor
和正 大場
泰 野々口
雅明 田口
隆正 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seiko Epson Corp
Aska Pharmaceutical Co Ltd
Original Assignee
Seiko Epson Corp
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seiko Epson Corp, Teikoku Hormone Manufacturing Co Ltd filed Critical Seiko Epson Corp
Priority to JP61206513A priority Critical patent/JPH0684355B2/en
Priority to US07/091,660 priority patent/US4980082A/en
Priority to DE3789797T priority patent/DE3789797T2/en
Priority to EP87307743A priority patent/EP0262809B1/en
Publication of JPS6363665A publication Critical patent/JPS6363665A/en
Publication of JPH0684355B2 publication Critical patent/JPH0684355B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Liquid Crystal Substances (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 この発明は、新規な液晶化合物を提供するものである。
本発明によって提供される液晶化合物は、強誘電性カイ
ラルスメクチック液晶化合物とブレンドして、電気光学
的効果を利用した液晶表示装置,オプティカルシャッタ
ー等,電気光学装置の作成に使用されるものである。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention provides a novel liquid crystal compound.
The liquid crystal compound provided by the present invention is blended with a ferroelectric chiral smectic liquid crystal compound, and is used for producing an electro-optical device such as a liquid crystal display device, an optical shutter or the like utilizing an electro-optical effect.

〔従来の技術〕[Conventional technology]

液晶化合物として数多く知られているものに、ネマチッ
ク液晶と呼ばれているものがある。このものは、現在、
液晶表示装置に使用されているものの主流をなしている
けれども、表示の大容量化に対しては限界に近づいてい
ると言われている。
Many known liquid crystal compounds include a so-called nematic liquid crystal. This one is currently
Although it is mainly used for liquid crystal display devices, it is said that it is approaching the limit for increasing the display capacity.

強誘電性液晶は、高速応答性とメモリ性を持っているた
め、次世代の液晶として注目を集め、盛んに研究されて
いる。その中に、(S)−2−メチルブチルp−(p−
n−デシロキシベンジリデンアミノ)シンナメート(DO
BAMBC)がよく知られた化合物としてある。しかし、こ
の化合物は、液晶性を示す温度が60℃以上という高い温
度であるため、使用に際して温度的制限を受ける。
Ferroelectric liquid crystals, which have high-speed response and memory properties, have attracted attention as next-generation liquid crystals and are being actively studied. Among them, (S) -2-methylbutyl p- (p-
n-decyloxybenzylideneamino) cinnamate (DO
BAMBC) is a well-known compound. However, since this compound has a high liquid crystallinity of 60 ° C. or higher, it is limited in temperature during use.

室温を含む広い温度範囲で液晶性を示す強誘電性カイラ
ルスメクチック液晶を得るために、化合物それ自体の創
製あるいはブレンドによる性能の改善に多くの努力が払
われている。
In order to obtain a ferroelectric chiral smectic liquid crystal that exhibits liquid crystallinity in a wide temperature range including room temperature, many efforts have been made to improve the performance by creating the compound itself or blending it.

本発明によって提供される液晶化合物と同じ骨格である
2−フェニルピリミジンを骨格に持つ液晶化合物はH.ZA
SCHKEが1975年にJournal f.prakt.Chemie317巻617ペー
ジに発表しているように公知であるが、骨格の両側に酸
素原子を介してアルキル基が結合している強誘電性カイ
ラルスメクチック液晶化合物は記されていない。性能の
すぐれた強誘電性カイラルスメクチック液晶化合物の出
現が望まれている。
The liquid crystal compound having 2-phenylpyrimidine, which has the same skeleton as the liquid crystal compound provided by the present invention, is H.ZA.
It is known that SCHKE published in 1975, Journal f.prakt.Chemie, Volume 317, page 617, but a ferroelectric chiral smectic liquid crystal compound in which an alkyl group is bonded to both sides of the skeleton through oxygen atoms is Not mentioned. It is desired to develop a ferroelectric chiral smectic liquid crystal compound having excellent performance.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明は、新規な液晶化合物を提供するものであって、
強誘電性液晶化合物又は組成物にブレンドし、その特性
を改善する液晶化合物である。
The present invention provides a novel liquid crystal compound,
A liquid crystal compound that is blended with a ferroelectric liquid crystal compound or composition to improve its properties.

〔問題点を解決するための手段〕[Means for solving problems]

本発明によって提供される新規な液晶化合物は次の一般
式で示されるものである。即ち、 (式中Rは炭素鎖が直鎖であるアルキル基又はアルコキ
シ基を、R*(R1はC1〜C5のアルキル基、R2はC1〜C4のアルキル基、
nは整数を示す)で示される鎖中に不斉炭素原子を有す
る光学的に活性な基を示す。) で示される。
The novel liquid crystal compound provided by the present invention is represented by the following general formula. That is, (In the formula, R is an alkyl group or an alkoxy group having a straight carbon chain, and R * is (R 1 is a C 1 -C 5 alkyl group, R 2 is a C 1 -C 4 alkyl group,
n represents an integer) and represents an optically active group having an asymmetric carbon atom in the chain. ).

式(I)で示される化合物は、式(II) (式中Rは前記と同じ) で示される化合物と式(III) (式中R*は前記と同じ) で示される化合物又はその反応性誘導体との反応により
造られる。
The compound represented by the formula (I) has the formula (II) (Wherein R is the same as above) and a compound of formula (III) (In the formula, R * is the same as above), or a reactive derivative thereof.

ここにおいて用いられる式(II)で示される化合物にお
ける置換基Rは、直鎖のアルキル基又はアルコキシ基で
あって、例えばペンチル,ヘキシル,ヘプチル,オクチ
ル,ノニル,デカニル,ウンデシル,ドデシル,ペンチ
ルオキシ,ヘキシルオキシ,ヘプチルオキシ,ノニルオ
キシ,デカニルオキシ,ウンデシルオキシ,ドデシルオ
キシなどが挙げられ、式(III)で示される化合物にお
ける置換基R*は不斉炭素原子を有する光学的に活性なア
ルキル基で活性炭素原子に直接結合している元素の一つ
が酸素原子であるものであって、 (R1はC1〜C5のアルキル基、R2はC1〜C4のアルキル基、
nは整数)で示され、C*のまわりの立体配置はS体又は
R体を示し、これらの基を例示すれば、例えば(S)
(又は(R))−2−メトキシブチル、(S)(又は
(R))−2−エトキシブチル、(S)(又は(R))
−2−ブトキシブチル、(S)(又は(R))−2−メ
トキシプロピル、(S)(又は(R))−2−エトキシ
プロピル、(S)(又は(R))−3−メトキシブチ
ル、(S)(又は(R))−3−エトキシペンチルなど
が挙げられる。反応は、両者を適宜溶媒(例えば酢酸エ
チル,酢酸メチル,エチルエーテル,テトラヒドロフラ
ン,ジオキサン,ジメチルホルムアミド,ジメチルスル
ホキシド,エチレングリコールジメチルエーテルなど)
に溶かし、N,N′−ジシクロヘキシルカルボジイミド,
塩化チオニル,オキシ塩化燐などの縮合剤を用いて行わ
れる。4−ジメチルアミノピリジン,ジメチルアニリ
ン,トリエチルアミンなどの三級アミンを併用すると反
応がスムースに進行する。
The substituent R in the compound represented by the formula (II) used herein is a linear alkyl group or an alkoxy group, and is, for example, pentyl, hexyl, heptyl, octyl, nonyl, decanyl, undecyl, dodecyl, pentyloxy, Hexyloxy, heptyloxy, nonyloxy, decanyloxy, undecyloxy, dodecyloxy and the like can be mentioned. The substituent R * in the compound represented by the formula (III) is an optically active alkyl group having an asymmetric carbon atom. One of the elements directly bonded to the carbon atom is an oxygen atom, (R 1 is a C 1 -C 5 alkyl group, R 2 is a C 1 -C 4 alkyl group,
n is an integer), and the configuration around C * is S or R, and if these groups are exemplified, for example, (S)
(Or (R))-2-methoxybutyl, (S) (or (R))-2-ethoxybutyl, (S) (or (R))
-2-butoxybutyl, (S) (or (R))-2-methoxypropyl, (S) (or (R))-2-ethoxypropyl, (S) (or (R))-3-methoxybutyl , (S) (or (R))-3-ethoxypentyl and the like. In the reaction, both are appropriately used as a solvent (eg, ethyl acetate, methyl acetate, ethyl ether, tetrahydrofuran, dioxane, dimethylformamide, dimethyl sulfoxide, ethylene glycol dimethyl ether, etc.)
Dissolved in N, N'-dicyclohexylcarbodiimide,
It is carried out using a condensing agent such as thionyl chloride or phosphorus oxychloride. The reaction proceeds smoothly when a tertiary amine such as 4-dimethylaminopyridine, dimethylaniline or triethylamine is used in combination.

式(III)で示される化合物の反応性誘導体を使用する
場合における反応性誘導体としては、酸ハライド(例え
ば塩化チオニルで造られる酸クロリド),活性エステル
(例えばp−ニトロフェノールで造られる),混合酸無
水物(例えばエトキシカルボニルクロリドからつくられ
る)などが挙げられ、三級アミンの共存下に反応に供さ
れる。原料として用いられる化合物(II)はβ−ジメチ
ルアミノ−α−(n−アルキル又はアルコキシ)アクロ
レインとヒドロキシベンズアミジンとから造られる。一
方、化合物(III)は光学活性な乳酸を原料として、こ
れに化学的装飾を繰り返しnを変化させて造る。例えば このサイクルを繰り返すことによって炭素が一個づつ増
加した。つまりnが一個づつ増えた光学的に活性なアル
コールが得られるので、これを用いて例えば、 のような反応性誘導体に導いたのち、ヒドロキシフェニ
ル安息香酸エステルと反応させ、脱ピリニルののち、水
酸基をアルキルハライド(R2X)でアルキル化して、加
水分解することによって、 を得ることができる。
When the reactive derivative of the compound represented by the formula (III) is used, examples of the reactive derivative include an acid halide (for example, an acid chloride formed with thionyl chloride), an active ester (for example, p-nitrophenol), and a mixture. An acid anhydride (made of, for example, ethoxycarbonyl chloride) and the like can be mentioned, which are subjected to the reaction in the presence of a tertiary amine. The compound (II) used as a raw material is made from β-dimethylamino-α- (n-alkyl or alkoxy) acrolein and hydroxybenzamidine. On the other hand, the compound (III) is produced by using optically active lactic acid as a raw material and repeating chemical decoration to change the n. For example Carbon was increased by one by repeating this cycle. In other words, since an optically active alcohol in which n is increased by 1 is obtained, using this, for example, After reacting with hydroxyphenyl benzoic acid ester, after depyrinylation, the hydroxyl group is alkylated with alkyl halide (R 2 X) and hydrolyzed. Can be obtained.

また、R*におけるR1がC1〜C5を示す場合の原料は次のよ
うにして造られる。
In addition, the raw material in the case where R 1 in R * represents C 1 to C 5 is prepared as follows.

R1がC2であるR*はノルバリンを、R1がC3であるR*はノル
ロイシンをそれぞれ原料とし、ジアゾ化し、得られたジ
アゾ化合物を加水分解して、α−ヒドロキシカルボン酸
を得、先の例に倣ってジヒドロピランと反応させ次いで
エステル化したのち、これを還元してアルコールとな
し、反応性誘導体(例えばp−トルエンスルホン酸)に
導いたのち、ヒドロキシフェニル安息香酸エステルと反
応させ、脱ピラニルののち、水酸基をアルキル化して、
加水分解することによって を得ることができる。
The R * is norvaline R 1 is C 2, R * R 1 is C 3 is set to each raw material norleucine, diazotized, and hydrolyzing the resulting diazo compound to obtain a α- hydroxy carboxylic acids Following the above example, after reacting with dihydropyran and then esterifying it, it is reduced to alcohol to form a reactive derivative (for example, p-toluenesulfonic acid) and then reacted with hydroxyphenyl benzoate. After depyranylation, the hydroxyl group is alkylated,
By hydrolyzing Can be obtained.

本発明の液晶化合物は、巾広い温度巾でコレステリック
相を有し、強誘電性カイラルスメクチック相を有しない
ものが多いが、強誘電性液晶化合物又は組成物とブレン
ドして、Sc*相の温度領域を上下に広げたり、応答性を
改善したりすることが出来る。
Most of the liquid crystal compounds of the present invention have a cholesteric phase over a wide temperature range and do not have a ferroelectric chiral smectic phase, but when blended with a ferroelectric liquid crystal compound or composition, the temperature of the Sc * phase is increased. The area can be expanded vertically and the responsiveness can be improved.

以下実施例を記述して本発明を具体的に説明する。The present invention will be specifically described with reference to the following examples.

実施例1 (S)−2−{4′−〔4″−(2−メトキシ)ブトキ
シ〕ベンゾイルオキシ}−5−n−オクチルオキシピリ
ミジンの合成: 1.0g(0.0045モル)の(S)−4−(2−メトキシブト
キシ)安息香酸及び1.34g(0.0045モル)の2−(4−
ヒドロキシ)フェニル−5−n−オクチルオキシピリミ
ジンを30mlの酢酸エチルに溶かし、この中に1.1g(0.00
53モル)のN,N′−ジシクロヘキシルカルボジイミド及
び50mg(0.041ミリモル)の4−ジメチルアミノピリジ
ンを加え、室温で7時間反応させた。終了後水にあけ、
酢酸エチルで抽出し、10%水酸化ナトリウム水溶液,
水,飽和食塩水の順に洗浄し、硫酸マグネシウムで乾燥
後、濃縮した。これをシリカゲルカラムクロマトグラフ
ィーで精製し、さらにエタノールで再結晶することによ
り、0.48gの白色結晶を得た。
Example 1 Synthesis of (S) -2- {4 '-[4 "-(2-methoxy) butoxy] benzoyloxy} -5-n-octyloxypyrimidine: 1.0 g (0.0045 mol) of (S) -4. -(2-Methoxybutoxy) benzoic acid and 1.34 g (0.0045 mol) of 2- (4-
Hydroxy) phenyl-5-n-octyloxypyrimidine was dissolved in 30 ml of ethyl acetate, and 1.1 g (0.00
53 mol) of N, N'-dicyclohexylcarbodiimide and 50 mg (0.041 mmol) of 4-dimethylaminopyridine were added, and the mixture was reacted at room temperature for 7 hours. After completion, pour in water,
Extracted with ethyl acetate, 10% aqueous sodium hydroxide solution,
The extract was washed with water and saturated brine in that order, dried over magnesium sulfate, and concentrated. This was purified by silica gel column chromatography and recrystallized from ethanol to obtain 0.48 g of white crystals.

▲〔α〕25 D▼=−12.0°(C 2.00,CHCl3) IRνmaxcm-1:1740,1555,1470,1250,1100,1080,885,840,
780,760 ′H−NMR(CDCl3,60MHz)δ(ppm): 0.66〜2.07(m,20H) 3.27〜3.70(s,1H) 3.43 (s,3H) 3.90〜4.23(m,4H) 6.93 (d,2H) 7.27 (d,2H) 8.10 (d,2H) 8.37 (d,2H) 8.40 (s,2H) この化合物の転移温度を以下に記す。
▲ 〔α〕 25 D ▼ = -12.0 ° (C 2.00, CHCl 3 ) IRν max cm -1 : 1740,1555,1470,1250,1100,1080,885,840,
780,760'H-NMR (CDCl 3 , 60MHz) δ (ppm): 0.66 ~ 2.07 (m, 20H) 3.27 ~ 3.70 (s, 1H) 3.43 (s, 3H) 3.90 ~ 4.23 (m, 4H) 6.93 (d, 2H) 7.27 (d, 2H) 8.10 (d, 2H) 8.37 (d, 2H) 8.40 (s, 2H) The transition temperatures of this compound are shown below.

実施例2 (S)−2−{4′−〔4″−(2−メトキシ)ブトキ
シ〕ベンゾイルオキシ}−5−n−オクチルピリミジン
の合成: 0.4g(0.0018モル)の(S)−4−(2−メトキシ)ブ
トキシ安息香酸、0.54g(0.0018モル)の2−(4−ヒ
ドロキシ)フェニル−5−n−オクチルピリミジン、10
mlの酢酸エチル、0.41g(0.002モル)のN,N′−ジシク
ロヘキシルカルボジイミド及び20mg(0.016ミリモル)
の4−ジメチルアミノピリジンを室温で9時間反応後、
実施例1と同様の方法に従って、0.2gの白色結晶を得
た。
Example 2 Synthesis of (S) -2- {4 '-[4 "-(2-methoxy) butoxy] benzoyloxy} -5-n-octylpyrimidine: 0.4 g (0.0018 mol) of (S) -4- (2-Methoxy) butoxybenzoic acid, 0.54 g (0.0018 mol) 2- (4-hydroxy) phenyl-5-n-octylpyrimidine, 10
ml ethyl acetate, 0.41 g (0.002 mol) N, N'-dicyclohexylcarbodiimide and 20 mg (0.016 mmol)
4-dimethylaminopyridine was reacted at room temperature for 9 hours,
Following the same procedure as in Example 1, 0.2 g of white crystals was obtained.

▲〔α〕25 D▼=−12.9°(C 1.52,CHCl3) IRνmaxcm-1:1745,1610,1430,1260,1200,1165,1080 ′H−NMR(CDCl3,60MHz)δ(ppm): 0.70〜2.00(m,20H) 2.80〜2.43(m,2H) 3.33〜3.67(m,1H) 3.43 (s,3H,-OCH3) 4.03 (d,2H) 6.94 (d,2H) 7.20 (s,2H) 7.27 (d,2H) 8.10 (d,2H) 8.43 (d,2H) 8.55 (d,2H) この化合物の転移温度を以下に記す。▲ 〔α〕 25 D ▼ = -12.9 ° (C 1.52, CHCl 3 ) IRν max cm -1 : 1745,1610,1430,1260,1200,1165,1080 ′ H-NMR (CDCl 3 , 60MHz) δ (ppm ): 0.70~2.00 (m, 20H) 2.80~2.43 (m, 2H) 3.33~3.67 (m, 1H) 3.43 (s, 3H, -OCH 3) 4.03 (d, 2H) 6.94 (d, 2H) 7.20 ( s, 2H) 7.27 (d, 2H) 8.10 (d, 2H) 8.43 (d, 2H) 8.55 (d, 2H) The transition temperatures of this compound are shown below.

実施例3 (S)−2−{4′−〔4″−(2−エトキシ)プロポ
キシ〕ベンゾイルオキシ}−5−n−オクチルオキシピ
リミジンの合成: 0.5g(0.0022モル)の(S)−4−(2−エトキシ)プ
ロポキシ安息香酸、0.67g(0.0022モル)の2−(4−
ヒドロキシ)フェニル−5−n−オクチルオキシピリミ
ジン、18mlの酢酸エチル、0.51g(0.0025モル)のN,N′
−ジシクロヘキシルカルボジイミド及び30mg(0.025ミ
リモル)の4−ジメチルアミノピリジンを室温で23時間
反応後、実施例1と同様の操作を行うことにより、0.33
gの白色結晶を得た。
Example 3 Synthesis of (S) -2- {4 ′-[4 ″-(2-ethoxy) propoxy] benzoyloxy} -5-n-octyloxypyrimidine: 0.5 g (0.0022 mol) of (S) -4 -(2-Ethoxy) propoxybenzoic acid, 0.67 g (0.0022 mol) of 2- (4-
Hydroxy) phenyl-5-n-octyloxypyrimidine, 18 ml of ethyl acetate, 0.51 g (0.0025 mol) of N, N '
-Dicyclohexylcarbodiimide and 30 mg (0.025 mmol) of 4-dimethylaminopyridine were reacted at room temperature for 23 hours, and then the same operation as in Example 1 was carried out to give 0.33.
White crystals of g were obtained.

▲〔α〕25 D▼=−11.0°(C 2.00,CHCl3) IRνmaxcm-1:1740,1470,1450,1250,1080,885,780,760 ′H−NMR(CDCl3,60MHz)δ(ppm): 0.50〜2.13(m,21H) 3.42〜3.90(m,3H) 3.90〜4.30(m,4H) 6.90 (d,2H) 7.28 (d,2H) 8.13 (d,2H) 8.41 (d,2H) 8.42 (s,2H) この化合物の転移温度を以下に記す。▲ 〔α〕 25 D ▼ = -11.0 ° (C 2.00, CHCl 3 ) IRν max cm -1 : 1740,1470,1450,1250,1080,885,780,760 ′ H-NMR (CDCl 3 , 60MHz) δ (ppm): 0.50 to 2.13 (m, 21H) 3.42 to 3.90 (m, 3H) 3.90 to 4.30 (m, 4H) 6.90 (d, 2H) 7.28 (d, 2H) 8.13 (d, 2H) 8.41 (d, 2H) 8.42 ( s, 2H) The transition temperature of this compound is shown below.

実施例4 実施例1〜3と同様にして合成した液晶化合物(S)−
2−{4′−〔4″−(2−メトキシ)プロポキシ〕ベ
ンゾイルオキシ}−5−n−オクテルピリミジンは、以
下の転移温度を示した。
Example 4 Liquid crystal compound (S) -synthesized in the same manner as in Examples 1 to 3.
2- {4 '-[4 "-(2-methoxy) propoxy] benzoyloxy} -5-n-octerpyrimidine showed the following transition temperatures.

実施例5 実施例1,2,4の化合物を以下の強誘電性液晶組成物Aに
ブレンドし、特性を比較した。
Example 5 The compounds of Examples 1, 2, and 4 were blended with the following ferroelectric liquid crystal composition A to compare the characteristics.

組成物A ここで応答速度は1.7μmのセルに封入し、±20Vのパル
ス波形を印加し、表示が切りかわる最小のパルス巾とし
て求めた。
Composition A Here, the response speed was enclosed in a 1.7 μm cell, a pulse waveform of ± 20 V was applied, and the minimum pulse width at which the display was switched was obtained.

表に示したように、組成物Aに本発明の化合物を適量ブ
レンドすることにより、Sc*相の温度巾を上下に広げる
事ができる。また、SA相の上にCh相をもった組成物を得
ることができる。
As shown in the table, the temperature range of the Sc * phase can be increased or decreased by blending the compound A of the present invention in an appropriate amount. Further, a composition having a Ch phase on the SA phase can be obtained.

更に、組成物Aと実施例4の化合物のブレンドの例のよ
うに、応答速度を改善することも可能である。
Further, it is also possible to improve the response speed, as in the case of the blend of the composition A and the compound of Example 4.

参考例1 (S)−エチル4−(2−テトラヒドロピラニルオキ
シ)ブトキシ安息香酸エステルの合成: 1.6g(0.033モル)の50%水素化ナトリウムと50mlのジ
メチルホルムアミドを室温で攪拌させながら5g(0.030
モル)のエチル4−ヒドロキシ安息香酸エステルを加
え、30分間攪拌後、9.9g(0.030モル)の(S)−2−
テトラヒドロピラニルオキシブトキシp−トルエンスル
ホン酸エステルを加えて80℃で10時間攪拌した。終了
後、氷水にあけ、酢酸エチルで抽出し、10%水酸化ナト
リウム水溶液,次いで飽和食塩水で洗浄し、硫酸マグネ
シウムで乾燥後、濃縮して8.8gの粗生成物を得た。
Reference Example 1 Synthesis of (S) -ethyl 4- (2-tetrahydropyranyloxy) butoxybenzoate: 1.6 g (0.033 mol) of 50% sodium hydride and 50 ml of dimethylformamide were stirred at room temperature to give 5 g ( 0.030
Mol) of ethyl 4-hydroxybenzoic acid ester, and after stirring for 30 minutes, 9.9 g (0.030 mol) of (S) -2-
Tetrahydropyranyloxybutoxy p-toluenesulfonic acid ester was added and stirred at 80 ° C. for 10 hours. After the completion, the mixture was poured into ice water, extracted with ethyl acetate, washed with 10% aqueous sodium hydroxide solution and then saturated brine, dried over magnesium sulfate, and concentrated to obtain 8.8 g of a crude product.

IRνmaxcm-1:1720,1605,1515,1280〜1250(br),1170,1
030,770 参考例2 (S)−エチル4−(2−ヒドロキシ)ブトキシ安息香
酸エステルの合成: 8.5g(0.026モル)の(S)−エチル4−(2−テトラ
ヒドロピラニルオキシ)ブトキシ安息香酸エステルを43
mlのエタノールに溶かし、0.2g(0.0011モル)のp−ト
ルエンスルホン酸1水塩を加えて3時間還流を行った。
終了後、濃縮し、水を加えて酢酸エチルで抽出し、水洗
し、硫酸マグネシウムで乾燥後、濃縮した。これをシリ
カゲルカラムクロマトグラフィーで精製することにより
3.4gの白色結晶を得た。
IRν max cm -1 : 1720,1605,1515,1280 ~ 1250 (br), 1170,1
Reference Example 2 Synthesis of (S) -ethyl 4- (2-hydroxy) butoxybenzoic acid ester: 8.5 g (0.026 mol) of (S) -ethyl 4- (2-tetrahydropyranyloxy) butoxybenzoic acid ester 43
It was dissolved in ml of ethanol, 0.2 g (0.0011 mol) of p-toluenesulfonic acid monohydrate was added, and the mixture was refluxed for 3 hours.
After the completion, the reaction mixture was concentrated, water was added, the mixture was extracted with ethyl acetate, washed with water, dried over magnesium sulfate, and concentrated. By purifying this with silica gel column chromatography
3.4 g of white crystals were obtained.

IRνmaxcm-1:3600〜3200(br),1710,1610,1515,1290〜
1230(br),1170,1100,850,770 参考例3 (S)−エチル4−(2−メトキシ)ブトキシ安息香酸
エステルの合成: 0.44g(0.0092モル)の50%水素化ナトリウム、15mlの
テトラヒドロフランを室温で攪拌しながら2.0g(0.0084
モル)の(S)−エチル4−(2−ヒドロキシ)ブトキ
シ安息香酸エステルを加え、さらに0.2g(0.0011モル)
のヘキサメチルホスホリックトリアミドを加え、1時間
攪拌後1.43g(0.01モル)のヨウ化メチルを加えて40℃
で1.5時間攪拌した。反応終了後、氷水にあけ、酢酸エ
チルで抽出し、10%水酸化ナトリウム水溶液,水,飽和
食塩水で順に洗浄し、硫酸マグネシウムで乾燥後、濃縮
して1.9gの粗生成物を得た。
IR ν max cm -1 : 3600 ~ 3200 (br), 1710,1610,1515,1290 ~
1230 (br), 1170,1100,850,770 Reference Example 3 Synthesis of (S) -ethyl 4- (2-methoxy) butoxybenzoic acid ester: 0.44 g (0.0092 mol) of 50% sodium hydride, 15 ml of tetrahydrofuran at room temperature 2.0g (0.0084
Mol) of (S) -ethyl 4- (2-hydroxy) butoxybenzoic acid ester was added, and 0.2 g (0.0011 mol) was further added.
Hexamethylphosphoric triamide is added and stirred for 1 hour, then 1.43 g (0.01 mol) of methyl iodide is added and the temperature is 40 ° C.
It was stirred for 1.5 hours. After completion of the reaction, the mixture was poured into ice water, extracted with ethyl acetate, washed successively with 10% aqueous sodium hydroxide solution, water and saturated brine, dried over magnesium sulfate, and concentrated to obtain 1.9 g of a crude product.

IRνmaxcm-1:1710,1605,1515,1280,1250,1170,1100,85
0,770 参考例4 (S)−4−(2−メトキシ)ブトキシ安息香酸の合
成: 1.9g(0.0075モル)の(S)−エチル4−(2−メトキ
シ)ブトキシ安息香酸エステルを10mlのエタノールに溶
かし、5mlの10%水酸化ナトリウム水溶液を加えて30分
間攪拌後、塩酸酸性にし、酢酸エチルで抽出し、重曹水
溶液で洗浄し、硫酸マグネシウムで乾燥後濃縮して1.9g
の油状物を得た。これにn−ヘキサンを加えて結晶化さ
せ、濾取し、n−ヘキサンで洗浄後、乾燥して1.2gの目
的化合物を得た。
IRν max cm -1 : 1710,1605,1515,1280,1250,1170,1100,85
Reference Example 4 Synthesis of (S) -4- (2-methoxy) butoxybenzoic acid: 1.9 g (0.0075 mol) of (S) -ethyl 4- (2-methoxy) butoxybenzoic acid ester was dissolved in 10 ml of ethanol. , 5 ml of 10% aqueous sodium hydroxide solution was added and stirred for 30 minutes, acidified with hydrochloric acid, extracted with ethyl acetate, washed with aqueous sodium hydrogen carbonate solution, dried over magnesium sulfate and concentrated to 1.9 g.
An oily substance was obtained. To this, n-hexane was added for crystallization, which was collected by filtration, washed with n-hexane, and dried to obtain 1.2 g of the target compound.

IRνmaxcm-1:3100〜2500,1680,1605,1430,1300,1255,85
0,770 640 ′H−NMR(CDCl3,60MHz)δ(ppm): 0.87〜1.37(m,3H) 1.37〜1.93(m,2H) 3.27〜3.63(m,1H) 3.43 (s,3H) 4.00 (d,2H) 6.87 (d,2H) 7.97 (d,2H) 9.87 (br,1H) 参考例5 (S)−エチル4−(2−テトラヒドロピラニルオキ
シ)プロポキシ安息香酸エステルの合成: 1.0g(0.021モル)の50%水素化ナトリウム、25mlのジ
メチルホルムアミド、3.2g(0.019モル)のエチル4−
ヒドロキシ安息香酸エステル及び6.1g(0.019モル)の
(S)−2−テトラヒドロピラニルオキシプロポキシp
−トルエンスルホン酸エステルを60℃で8時間反応さ
せ、参考例1と同様の操作を行い5.0gの粗生成物を得
た。
IRν max cm -1 : 3100 ~ 2500,1680,1605,1430,1300,1255,85
0,770 640'H-NMR (CDCl 3 , 60MHz) δ (ppm): 0.87 to 1.37 (m, 3H) 1.37 to 1.93 (m, 2H) 3.27 to 3.63 (m, 1H) 3.43 (s, 3H) 4.00 (d , 2H) 6.87 (d, 2H) 7.97 (d, 2H) 9.87 (br, 1H) Reference Example 5 Synthesis of (S) -ethyl 4- (2-tetrahydropyranyloxy) propoxybenzoic acid ester: 1.0 g (0.021 Mol) 50% sodium hydride, 25 ml dimethylformamide, 3.2 g (0.019 mol) ethyl 4-
Hydroxybenzoic acid ester and 6.1 g (0.019 mol) of (S) -2-tetrahydropyranyloxypropoxy p
-Toluenesulfonic acid ester was reacted at 60 ° C for 8 hours, and the same operation as in Reference Example 1 was performed to obtain 5.0 g of a crude product.

IRνmaxcm-1:1715,1610,1280,1255,1170,1120,1035,770 参考例6 (S)−エチル4−(2−ヒドロキシ)プロポキシ安息
香酸エステルの合成: 4.5g(0.014モル)の(S)−エチル4−(2−テトラ
ヒドロピラニルオキシ)プロポキシ安息香酸エステル、
0.2g(0.0011モル)のp−トルエンスルホン酸1水塩及
び45mlのメタノールの混合物を1時間還流し、参考例2
と同様の操作を行い2.2gの粗生成物を得た。
IRν max cm -1 : 1715,1610,1280,1255,1170,1120,1035,770 Reference Example 6 Synthesis of (S) -ethyl 4- (2-hydroxy) propoxybenzoic acid ester: 4.5 g (0.014 mol) (S) -ethyl 4- (2-tetrahydropyranyloxy) propoxybenzoic acid ester,
A mixture of 0.2 g (0.0011 mol) of p-toluenesulfonic acid monohydrate and 45 ml of methanol was refluxed for 1 hour, and then Reference Example 2 was used.
The same operation as the above was performed to obtain 2.2 g of a crude product.

IRνmaxcm-1:3600〜3200(br),1710(br),1610,1515,
1300〜1220(br),1170,1100,1030,770 参考例7 (S)−4−(2−エトキシ)プロポキシ安息香酸の合
成: 0.52g(0.011モル)の50%水素化ナトリウムと15mlのテ
トラヒドロフランを攪拌しながら、2.2g(0.0098モル)
の(S)−エチル4−(2−ヒドロキシ)プロポキシ安
息香酸エステル、0.2g(0.0011モル)のヘキサメチルホ
スホリックトリアミドを加えて1時間後、1.8g(0.012
モル)のヨウ化メチルを加え2時間還流を行った。終了
後、氷水にあけ、酢酸エチルで抽出し、10%水酸化ナト
リウム水溶液,飽和食塩水で洗浄し、硫酸マグネシウム
で乾燥後、濃縮した。これに20mlのエタノールを加えて
溶かし、10%水酸化ナトリウム水溶液を加え1時間還流
することにより加水分解を行った。終了後、氷水にあ
け、酢酸エチルで抽出し、前段と同様の操作を行って1.
4gの油状物を得た。これをシリカゲルカラムクロマトグ
ラフィーで精製して0.76gの生成物を得た。
IR ν max cm -1 : 3600-3200 (br), 1710 (br), 1610,1515,
1300-1220 (br), 1170,1100,1030,770 Reference Example 7 Synthesis of (S) -4- (2-ethoxy) propoxybenzoic acid: 0.52 g (0.011 mol) of 50% sodium hydride and 15 ml of tetrahydrofuran 2.2g (0.0098mol) while stirring
Of (S) -ethyl 4- (2-hydroxy) propoxybenzoic acid ester and 0.2 g (0.0011 mol) of hexamethylphosphoric triamide were added, and 1 hour later, 1.8 g (0.012
(Mol) methyl iodide was added and the mixture was refluxed for 2 hours. After completion, the mixture was poured into ice water, extracted with ethyl acetate, washed with 10% aqueous sodium hydroxide solution and saturated saline, dried over magnesium sulfate, and concentrated. To this, 20 ml of ethanol was added to dissolve it, 10% aqueous sodium hydroxide solution was added, and the mixture was refluxed for 1 hour for hydrolysis. After completion, pour in ice water, extract with ethyl acetate, and perform the same operation as in the previous step 1.
4 g of oil was obtained. This was purified by silica gel column chromatography to obtain 0.76 g of product.

▲〔α〕25 D▼=−14.3°(C 1.05,CHCl3) IRνmaxcm-1:3300〜2400(br),1690,1610,1460,1250,1
170,850,770 ′H−NMR(CDCl3,60MHz)δ(ppm): 0.70〜1.90(m,6H) 3.40〜4.23(m,5H) 6.90 (d,2H) 8.03 (d,2H) 11.70 (br,1H)
▲ 〔α〕 25 D ▼ = -14.3 ° (C 1.05, CHCl 3 ) IRν max cm -1 : 3300 to 2400 (br), 1690,1610,1460,1250,1
170,850,770'H-NMR (CDCl 3 , 60MHz) δ (ppm): 0.70 ~ 1.90 (m, 6H) 3.40 ~ 4.23 (m, 5H) 6.90 (d, 2H) 8.03 (d, 2H) 11.70 (br, 1H)

───────────────────────────────────────────────────── フロントページの続き (72)発明者 田口 雅明 東京都江東区亀戸6丁目31番1号 セイコ ー電子工業株式会社内 (72)発明者 原田 隆正 東京都江東区亀戸6丁目31番1号 セイコ ー電子工業株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Masaaki Taguchi 6-31-1, Kameido, Koto-ku, Tokyo Seiko Electronics Co., Ltd. (72) Takamasa Harada 6-31-1, Kameido, Koto-ku, Tokyo Seiko Electronics Industry Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式 (式中Rは炭素鎖が直鎖であるアルキル基又はアルコキ
シ基を、R*(R1はC1〜C5のアルキル基、R2はC1〜C4のアルキル基、
nは整数を示す)で示される鎖中に不斉炭素原子を有す
る光学的に活性な基を示す。) で示されるピリミジノフェニルエステル誘導体。
1. A general formula (In the formula, R is an alkyl group or an alkoxy group having a straight carbon chain, and R * is (R 1 is a C 1 -C 5 alkyl group, R 2 is a C 1 -C 4 alkyl group,
n represents an integer) and represents an optically active group having an asymmetric carbon atom in the chain. ] The pyrimidino phenyl ester derivative shown by these.
JP61206513A 1986-09-02 1986-09-02 Pyrimidinophenyl ester derivative Expired - Fee Related JPH0684355B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP61206513A JPH0684355B2 (en) 1986-09-02 1986-09-02 Pyrimidinophenyl ester derivative
US07/091,660 US4980082A (en) 1986-09-02 1987-09-01 Ferroelectric SmC liquid crystal composition which comprises pyrimidinylphenyl ester compounds
DE3789797T DE3789797T2 (en) 1986-09-02 1987-09-02 Pyrimidinylphenyl ester compound.
EP87307743A EP0262809B1 (en) 1986-09-02 1987-09-02 Pyrimidinylphenyl ester compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61206513A JPH0684355B2 (en) 1986-09-02 1986-09-02 Pyrimidinophenyl ester derivative

Publications (2)

Publication Number Publication Date
JPS6363665A JPS6363665A (en) 1988-03-22
JPH0684355B2 true JPH0684355B2 (en) 1994-10-26

Family

ID=16524607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61206513A Expired - Fee Related JPH0684355B2 (en) 1986-09-02 1986-09-02 Pyrimidinophenyl ester derivative

Country Status (1)

Country Link
JP (1) JPH0684355B2 (en)

Also Published As

Publication number Publication date
JPS6363665A (en) 1988-03-22

Similar Documents

Publication Publication Date Title
US4873018A (en) Optically active compound, process for producing same and liquid crystal composition containing same
US5126071A (en) Optically active compound, process for producing same and liquid crystal composition containing same
US5149462A (en) Optically active compound
JPS58121248A (en) 4-fluorobiphenyl derivatives, manufacture and dielectric body and electrooptical display elements
EP0262809B1 (en) Pyrimidinylphenyl ester compound
JPH0645573B2 (en) Liquid crystal compound and liquid crystal composition
Wen et al. Novel fluorinated liquid crystals. II. The synthesis and phase transitions of a novel type of ferroelectric liquid crystals containing 1, 4-tetrafluorophenylene moiety
JPH0684355B2 (en) Pyrimidinophenyl ester derivative
US5211879A (en) Ester compounds and liquid crystal compositions containing the same
JP2646314B2 (en) Optically active 4-mercaptocinnamic acid derivative, production method thereof and use of the derivative
JPH0794446B2 (en) 2-phenylpyrimidine derivative
US5366656A (en) Optically active alcohol and derivatives thereof, liquid crystal composition containing same and liquid crystal device
JP2974824B2 (en) Optically active compound, synthetic intermediate thereof, and ferroelectric liquid crystal composition containing the same
JPH0717616B2 (en) Pyrimidinylphenyl ester derivative
US5360575A (en) Lactic acid derivatives having two asymmetric carbon atoms, liquid crystal composition containing same and liquid crystal device
JP2855346B2 (en) Optically active oxazolidone derivative, intermediate thereof, liquid crystal material and liquid crystal display device
JP2700339B2 (en) Novel ester compound and liquid crystal composition containing the same
JP2639385B2 (en) Novel lactic acid derivative and liquid crystal composition containing the same
JP2571943B2 (en) Benzoyloxyphenylpyrimidine derivative
JP2819038B2 (en) Optically active compound, intermediate thereof, liquid crystal composition and liquid crystal display device
JP2668028B2 (en) Pyrimidinylphenoxyalkyl ester compounds
JP2529859B2 (en) Pyrimidinyl phenyl ester derivative of acyloxybenzoic acid
JPH0830023B2 (en) Novel biphenyl compound, liquid crystal composition containing the same, and optical switching device
JP2732410B2 (en) Optically active lactic acid derivative
JP3095435B2 (en) Liquid crystal compound

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees